Clinical Trial Update: Chidamide, Venetoclax, and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia [NA]

View source ↗

Summary

A clinical trial evaluating the combination of chidamide, venetoclax, and azacitidine for newly diagnosed acute myeloid leukemia is currently recruiting in Chin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Chidamide (chidamide)
• Venetoclax (venetoclax)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: AML, Acute Myeloid Leukemia | NA | Status: RECRUITING